|
1. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 65(3):278-290, 2006. 2. Alberti S, Marques G, Hernandez-Alles S, Rubires X, Tomas JM, Vivanco F, and Benedi VJ. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infection & Immunity 64:4719-4725, 1996. 3. Allen BL, Gerlach GF, and Clegg S. Nucleotide sequence and functions of mrk determinants necessary for expression of type 3 fimbriae in Klebsiella pneumoniae. J Bacteriol 173:916-920, 1991. 4. Anastasi E, Dotta F, Tiberti C, Vecci E, Ponte E, Di Mario U. Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes. Autoimmunity. 29(4):249-256, 1999. 5. Bate KL, Jerums G. 3: Preventing complications of diabetes. Med J Aust. 179(9):498-503, 2003. 6. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle. 6(6):686-695, 2007. 7. Braiteh F, Golden MP. Cryptogenic invasive Klebsiella pneumoniae liver abscess syndrome. Int J Infect Dis. 11(1):16-22, 2007. 8. Boulogne A, Vantyghem MC. [Treatment principles for the metabolic syndrome] Presse Med. 33(10):673-681, 2004. 9. Caro JJ, Salas M, O''Brien JA, Ishak K, Sung J, Raggio G. Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States. Value Health. 7(1):13-21, 2004. 10. Chang FY, Shaio MF. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 28(2):137-146, 1995. 11. Chang SC, Fang CT, Hsueh PR, Chen YC and Luh KT. Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis. 37(4):279-284, 2000. 12. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271(5251):994-996, 1996. 13. Chi CC, Wang SH, Chou MC. The causative pathogens of onychomycosis in southern Taiwan. Mycoses. 48(6):413-420, 2005. 14. Christina L. Sherry, Jason C. O’Connor, Jason M. Kramer and Gregory G. Freund. Augmented Lipopolysaccharide-Induced TNF-a Production by Peritoneal Macrophages in Type 2 Diabetic Mice Is Dependent on Elevated Glucose and Requires p38 MAPK. The Journal of Immunology, 178:663-670, 2007. 15. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 25(4):246-252, 2003. 16. Egger L, Madden DT, Rhême C, Rao RV, Bredesen DE. Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ. 14(6):1172-1180, 2007. 17. Fang CT, Chuang YP, Shun CT, Chang SC, and Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. Journal of Experimental Medicine. 199:697-705, 2004. 18. Fang FC, Sandler N, and Libby SJ. Liver abscess caused by magA+ Klebsiella pneumoniae in North America. Journal of Clinical Microbiology. 43: 991-992, 2005. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, and Siu LK. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut. 50:420-424, 2002. 19. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 103(44):16502-16507, 2006. 20. Gerlach GF, Clegg S, and Allen BL. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol. 171:1262-1270, 1989. 21. Geerlings SE and Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 26(3-4):259-265, 1999. 22. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13(2):85-94, 2001. 23. Guha M, O''Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood. 98(5):1429-1439, 2001. 24. Geutskens SB, Mendes-da-Cruz DA, Dardenne M, Savino W. Fibronectin receptor defects in NOD mouse leucocytes: possible consequences for type 1 diabetes. Scand J Immunol. 60(1-2):30-38, 2004. 25. Goel A, Agarwal N, Singh FV, Sharon A, Tiwari P, Dixit M, Pratap R, Srivastava AK, Maulik PR, Ram VJ. Antihyperglycemic activity of 2-methyl-3, 4, 5-triaryl-1H-pyrroles in SLM and STZ models. Bioorg Med Chem Lett. 14(5):1089-1092, 2004. 26. Hoepelman AI, Meiland R, Geerlings SE. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents. l2:35-43, 2003. 27. Hostetter MK, Gordon DL. Biochemistry of C3 and related thiolester proteins in infection and inflammation. Rev Infect Dis. 9(1):97-109, 1987. 28. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK) from inflammation to development. Curr Opin Cell Biol. 10(2):205-219, 1998. 29. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis LA, Grue RM, Schlepper-Schafer J, Ezekowitz AR, and Ohman DE. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infection & Immunity. 63: 847-852, 1995. 30. Kajita Y, Majima T, Yoshimura M, Hachiya T, Miyazaki T, Ijichi H, Ochi Y. Demonstration of antibody for glutamic pyruvic transaminase (GPT) in chronic hepatic disorders. Clin Chim Acta. 89(3):485-492, 1978. 31. Klionsky DJ and Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 290:1717-1721, 2000. 32. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E, Momoi T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 14(2):230-239, 2007. 33. Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. BMJ. 322(7285):537-540, 2001. 34. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 55(1):65-85, 2002. 35. Lai YC, Peng HL, and Chang HY. Identification of genes induced in vivo during Klebsiella pneumoniae CG43 infection. Infection & Immunity. 69:7140-7145, 2001. 36. Lee HL, Lee HC, Guo HR, Ko WC, Chen KW. Clinical significance and mechanism of gas formation of pyogenic liver abscess due to Klebsiella pneumoniae. J Clin Microbiol. 42(6):2783-2785, 2004. 37. Lee SC, Chen KS, Tsai CJ, Lee CC, Chang HY, See LC, Kao YC, Chen SC, Wang CH. An outbreak of methicillin-resistant Staphylococcus aureus infections related to central venous catheters for hemodialysis. Infect Control Hosp Epidemiol. 25(8):678-684, 2004. 38. Leibovici L, Yehezkelli Y, Porter A, et al: Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabetic Med. 13:457-463, 1996. 39. Liu YM, Chi CY, Ho MW, Chen CM, Liao WC, Ho CM, Lin PC, Wang JH. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect. 38(6):430-435, 2005. 40. Mackowiak PA, Martin RM, and Smith JW. The role of bacterial interference in the increased prevalence of oropharyngeal gram-negative bacilli among alcoholics and diabetics. American Review of Respiratory Disease. 120:589-593, 1979. 41. Maroncle N, Balestrino D, Rich C, and Forestier C. Identification of Klebsiella pneumoniae genes involved in intestinal colonization and adhesion using signature-tagged mutagenesis. Infection & Immunity. 70:4729-4734, 2002. 42. Mary C, Abraham and Shai Shaham. Death without caspases, caspases without death. Trends Cell Biol. 14(4):184-193, 2004. 43. Merino S, Camprubi S, Alberti S, Benedi VJ, and Tomas JM. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun. 60:2529-2535, 1992. 44. Montgomerie JZ. Epidemiology of Klebsiella and hospital-associated infections. Reviews of Infectious Diseases. 1:736-753, 1979. 45. Moretti L, Cha YI, Niermann KJ, Lu B. Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress? Cell Cycle. 6(7):793-798, 2007. 46. Nassif X and Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infection & Immunity. 54:603-608, 1986. 47. Navarro JF, Mora-Fernández C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev. 17(6):441-450, 2006. 48. Orskov F, Sharma V, and Orskov I. Influence of growth temperature on the development of Escherichia coli polysaccharide K antigens. Journal of General Microbiology. 130(10):2681-2684, 1984. 49. Pei D, Kuo SW, Wu DA, Lin TY, Hseih MC, Lee CH, Hsu WL, Chen SP, Sheu WH, Li JC. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians. Int J Clin Pract. 59(12):1408-1416, 2005. 50. Ploska JF. [Caring for a patient with type 2 diabetes mellitus]. Rev Infirm. (49):27-31, 1999. 51. Podschun R and Ullmann U. Klebsiella capsular type K7 in relation to toxicity, susceptibility to phagocytosis and resistance to serum. Journal of Medical Microbiology. 36:250-254, 1992. 52. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 85(3):391-398, 1988. 53. Sherry CL, O''Connor JC, Kramer JM, Freund GG. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J Immunol. 178(2):663-670, 2007. 54. Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin. 20(3):295-304, 2004. 55. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 9(5):337-351, 1997. 56. Tan YM, Chee SP, Soo KC, Chow P. Ocular manifestations and complications of pyogenic liver abscess. World J Surg. 28(1):38-42, 2004. 57. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 36(12):2503-2518, 2004. 58. Temelkova-Kurktschiev T, Henkel E, Koehler C, Karrei K, Hanefeld M. Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia. 45(1):151, 2002. 59. Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med. 162(9):1021-1027, 2002. 60. Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med. 158(7):677-684, 2004. 61. Wu JH, Tsai CG. Infectivity of hepatic strain Klebsiella pneumoniae in diabetic mice. Exp Biol Med. 230(10):757-761, 2005. 62. Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Yamaguchi K. Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection. J Med Microbiol. 50(5):456-461, 2001. 63. Yang CC, Yen CH, Ho MW, Wang JH. Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae. J Microbiol Immunol Infect. 37(3):176-184, 2004. 64. Zhang K, Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 66:S102-109, 2006. 65. 詹明修,氯化鋰與Bad蛋白質對 ceramide 誘發細胞凋亡的調節機制,89年7月。 66. 湯惠玲. 探討臨床分離克雷伯氏肺炎桿菌的基因分型和臨床疾病的相關性. 台中市: 中國醫藥大學, 2004.
|